Drugs / T2310
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04044781 | Jan → Apr 2020 | — | Tetra Discovery Partners | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T2310 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04044781 ↗ |
| Modality | Diagnostic / imaging agent | “an investigational imaging agent for quantifying the topographically specific concentrations of the phosphodiesterase enzyme Type 4D (PDE4D) with positron emission tomography...” NCT04044781 ↗ |